Table 3.

Comparison of clinicopathologic features between tumors without BAF250a staining and controls without cancer

	Staining absent (n=96)	Controls (n=1085)	OR	CI
Age (years)
0-49	37(38.5%)	325(30.0%)	1(ref)	-
50-59	27(28.1%)	339(31.2%)	0.70	0.42-1.18
60-69	26(27.1%)	287(26.5%)	0.80	0.47-1.35
70+	6(6.3%)	134(12.4%)	0.39	0.16-.95
Endometriosis	19(20.0%)	69(6.4%)	3.58	2.04-6.27
History of infertility	17(17.7%)	101(9.3%)	2.06	1.17-3.62
Tubal ligation	16(16.7%)	398(36.7%)	0.34	0.20-0.60
Family history of breast or ovarian cancer	16(16.7%)	180(16.6%)	1.05	0.56-1.85
Oral contraceptive use
Never	28(30.1%)	308(28.4%)	1(ref)	-
0-1 years	12(12.9%)	108(10.0%)	1.13	0.55-2.32
1-5 years	27(29.0%)	291(26.8%)	0.88	0.49-1.58
5+ years	26(28.0%)	343(31.6%)	0.70	0.38-1.27
Missing	3(3.1%)	33(3.0%)